Adaptimmune

Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous or infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was incorporated in 2007 and is based in Abingdon, United Kingdom.

Type
Public
HQ
Philadelphia, US
Founded
2008
Size (employees)
173 (est)
Adaptimmune was founded in 2008 and is headquartered in Philadelphia, US

Adaptimmune Office Locations

Adaptimmune has offices in Philadelphia, Milton
Philadelphia, US (HQ)
2010 Market St
Milton, GB
Park House Park Dr

Adaptimmune Metrics

Adaptimmune Market Value History

Adaptimmune Online Presence

Adaptimmune News

Adaptimmune Company Life

You may also be interested in